Dulaglutide

Common brands: Trulicity, Metformin Hydrochloride, Metformin, Lantus, Jardiance

Top reporter: Eli Lilly And Company

GLP-1 Receptor Agonist [EPC]Insulin Analog [EPC]Sulfonylurea [EPC]Sodium-Glucose Cotransporter 2 Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
86,770
Total Reports
38,675
Serious Reports
1,632
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.88%)

Patient Demographics

Male
32,779
Female
45,048

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Dulaglutide.

# Reaction Reports % of Total
1 NAUSEA 10,199
9.8%
2 INJECTION SITE PAIN 9,872
9.5%
3 BLOOD GLUCOSE INCREASED 9,831
9.5%
4 DIARRHOEA 5,948
5.7%
5 VOMITING 5,608
5.4%
6 INCORRECT DOSE ADMINISTERED 5,535
5.3%
7 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3,831
3.7%
8 DRUG INEFFECTIVE 3,602
3.5%
9 WEIGHT DECREASED 3,390
3.3%
10 DECREASED APPETITE 3,227
3.1%
11 INJECTION SITE HAEMORRHAGE 3,145
3.0%
12 EXTRA DOSE ADMINISTERED 3,140
3.0%
13 GLYCOSYLATED HAEMOGLOBIN INCREASED 2,932
2.8%
14 FATIGUE 2,441
2.4%
15 ABDOMINAL PAIN UPPER 2,428
2.3%
16 ACCIDENTAL UNDERDOSE 2,360
2.3%
17 PRODUCT DOSE OMISSION ISSUE 2,252
2.2%
18 CONSTIPATION 2,246
2.2%
19 ABDOMINAL PAIN 2,211
2.1%
20 MALAISE 2,062
2.0%
21 INJECTION SITE BRUISING 1,930
1.9%
22 ACCIDENTAL OVERDOSE 1,872
1.8%
23 DIZZINESS 1,859
1.8%
24 BLOOD GLUCOSE DECREASED 1,834
1.8%
25 OFF LABEL USE 1,797
1.7%
26 ABDOMINAL DISCOMFORT 1,761
1.7%
27 HEADACHE 1,715
1.7%
28 INJECTION SITE ERYTHEMA 1,634
1.6%
29 IMPAIRED GASTRIC EMPTYING 1,593
1.5%
30 PANCREATITIS 1,512
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.